Patient Education Sheet Library
Search Results
Alemtuzumab
Alemtuzumab is used for B-cell chronic lymphocytic leukemia (B-CLL).
Treatment Given by InfusionDownloads:
Pegaspargase
Pegaspargase is used for acute lymphoblastic leukemia (ALL).
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Daunorubicin
Daunorubicin is used for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Treatment Given by InfusionDownloads:
Busulfan and Cyclophosphamide Conditioning for Allogeneic Transplant
The combination of busulfan and cyclophosphamide is used as conditioning chemotherapy before an allogeneic stem…
Treatment Given by InfusionDownloads:
Fludarabine and Busulfan Conditioning for Allogeneic Transplant
The combination of fludarabine and busulfan is used as conditioning chemotherapy before an allogeneic stem…
Treatment Given by InfusionDownloads:
Tocilizumab (Actemra)
Tocilizumab is used for cytokine release syndrome (CRS), a serious immune reaction caused by chimeric…
Treatment Given by InfusionDownloads:
Pertuzumab (Perjeta), Paclitaxel (Taxol), Carboplatin, and Trastuzumab (Herceptin) (P-TCH)
The combination of pertuzumab, paclitaxel, carboplatin, and trastuzumab (P-TCH) is used for breast cancer.
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Brentuximab Vedotin and CHP (Cyclophosphamide, Doxorubicin, Prednisone)
The combination of brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A-CHP) is used for systemic anaplastic…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Trastuzumab, Carboplatin, and Paclitaxel
The combination of trastuzumab, carboplatin, and paclitaxel is used for breast cancer and a type…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Pembrolizumab, Bevacizumab, Cisplatin, and Paclitaxel
The combination of pembrolizumab, bevacizumab, cisplatin, and paclitaxel is used for cervical cancer.
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
Download (English)